DNA methylation: New therapeutic implications for hepatic fibrosis

被引:26
作者
Bian, Er-Bao [1 ]
Huang, Cheng [1 ]
Wang, Hua [1 ]
Wu, Bao-Ming [1 ]
Zhang, Lei [1 ]
Lv, Xiong-wen [1 ]
Li, Jun [1 ]
机构
[1] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China
基金
美国国家科学基金会;
关键词
Liver fibrosis; Hepatic stellate cell; DNA methylation; Signaling pathway; STELLATE CELL ACTIVATION; TGF-BETA; SIGNALING PATHWAYS; GENE-EXPRESSION; LIVER FIBROSIS; CANCER-THERAPY; FIBROGENESIS; DNMT1; PROTEIN; MECP2;
D O I
10.1016/j.cellsig.2012.10.007
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
DNA methylation refers to a heritable alteration in the pattern of gene expression that is regulated by a mechanism specifically not owing to changes in the primary nucleotide sequence. The transcriptional silencing caused by DNA methylation affects genes involved in the main cellular pathways: cell cycle control. Ras signaling, apoptosis, and detoxification. Recent studies have shown that methylation modifications orchestrate the activation of hepatic stellate cells (HSCs) characterized by excessive accumulation of extracellular matrices (ECMs). The activation of HSCs is mediated by multiple signal transduction pathways and is generally regarded as the major ECM producer responsible for liver fibrosis. In addition, aberrant methylation of specific gene involved in the activation of multiple signal transduction pathways in liver fibrosis. The aim of this review is to compile recent information on aberrant DNA methylation in hepatic fibrosis and to highlight key genes and molecular pathways in hepatic fibrosis formation. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:355 / 358
页数:4
相关论文
共 52 条
[1]
DNA methylation and gene silencing in cancer [J].
Baylin S.B. .
Nature Clinical Practice Oncology, 2005, 2 (Suppl 1) :S4-S11
[2]
Methylation determines fibroblast activation and fibrogenesis in the kidney [J].
Bechtel, Wibke ;
McGoohan, Scott ;
Zeisberg, Elisabeth M. ;
Mueller, Gerhard A. ;
Kalbacher, Hubert ;
Salant, David J. ;
Mueller, Claudia A. ;
Kalluri, Raghu ;
Zeisberg, Michael .
NATURE MEDICINE, 2010, 16 (05) :544-U75
[3]
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats [J].
Bian, Er-Bao ;
Huang, Cheng ;
Ma, Tao-Tao ;
Tao, Hui ;
Zhang, Hui ;
Cheng, Chang ;
Lv, Xiong-Wen ;
Li, Jun .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 264 (01) :13-22
[4]
Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality [J].
Biniszkiewicz, D ;
Gribnau, J ;
Ramsahoye, B ;
Gaudet, F ;
Eggan, K ;
Humpherys, D ;
Mastrangelo, MA ;
Jun, Z ;
Walter, J ;
Jaenisch, R .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (07) :2124-2135
[5]
Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[6]
Brenner C, 2006, CURR TOP MICROBIOL, V301, P45
[7]
DNA Methylation of Cancer Genome [J].
Cheung, Hoi-Hung ;
Lee, Tin-Lap ;
Rennert, Owen M. ;
Chan, Wai-Yee .
BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS, 2009, 87 (04) :335-350
[8]
DNA methylation and cellular reprogramming [J].
De Carvalho, Daniel D. ;
You, Jueng Soo ;
Jones, Peter A. .
TRENDS IN CELL BIOLOGY, 2010, 20 (10) :609-617
[9]
DELSENNO L, 1986, CANCER DETECT PREV, V9, P9
[10]
Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome [J].
Dickstein, Jerome ;
Senyuk, Vitalyi ;
Premanand, Kavitha ;
Laricchia-Robbio, Leopoldo ;
Xu, Peng ;
Cattaneo, Francesca ;
Fazzina, Raffaella ;
Nucifora, Giuseppina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (21) :9783-9788